文献速递胸部肿瘤放疗放疗物理与技术

消融性大分割放疗通过优先刺激坏死性凋亡增强非小细胞肺癌杀伤

Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis In Vitro and In Vivo.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2018-01-31

本文研究消融性大分割放疗(HFRT)杀伤非小细胞肺癌(NSCLC)时坏死性凋亡的作用。体外和体内实验显示,单次≥10 Gy的消融性HFRT优先在高RIP3表达的NSCLC细胞和移植瘤中刺激坏死性凋亡;RIP3 RNA干扰可减弱该效应。接受立体定向体部放疗的早期NSCLC患者中,RIP3高表达与局部控制率和无进展生存期改善相关(均P<.05)。

要点

  • 单次≥10 Gy的消融性HFRT优先在高RIP3表达的NSCLC中诱导坏死性凋亡。
  • RIP3 RNA干扰可减弱消融性HFRT诱导的坏死性凋亡及其调控蛋白活化。
  • 早期NSCLC接受SBRT者,RIP3高表达与局部控制和无进展生存改善相关。

核心结论

  • 单次≥10 Gy的消融性HFRT通过优先刺激坏死性凋亡增强高RIP3表达NSCLC的杀伤。
  • RIP3可能作为预测立体定向体部放疗有利反应的生物标志物。

研究设计与样本

  • 体外评估NSCLC细胞系放疗后DNA损伤、修复和死亡形式。
  • 构建RIP3过表达和沉默的稳定NSCLC细胞系。
  • 体外表征放疗后细胞死亡形式、集落数目和面积及坏死性凋亡调控蛋白。
  • 体内使用NSCLC移植瘤和患者标本检验消融性HFRT后坏死性凋亡的参与。

主要发现

  • 放疗诱导NSCLC细胞系预期的DNA损伤和修复。
  • 单次≥10 Gy的消融性HFRT优先在高RIP3表达的NSCLC细胞和移植瘤中刺激坏死性凋亡。
  • 坏死性凋亡特征包括RIP3和混合谱系激酶结构域样蛋白的诱导与活化及免疫激活趋化因子高迁移率族蛋白B1的释放。
  • RIP3 RNA干扰减弱消融性HFRT诱导的坏死性凋亡及其调控蛋白活化。
  • 接受立体定向体部放疗的中央型早期NSCLC患者中,RIP3高表达与局部控制率和无进展生存期改善相关(均P<.05)。

临床怎么用

  • RIP3表达状态可能有助于预测NSCLC患者对立体定向体部放疗的应答。
  • 单次≥10 Gy的消融性HFRT方案可通过优先刺激坏死性凋亡增强高RIP3表达NSCLC的杀伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate how necroptosis (ie, programmed necrosis) is involved in killing of non-small cell lung cancer (NSCLC) after ablative hypofractionated radiation therapy (HFRT). METHODS AND MATERIALS: Deoxyribonucleic acid damage, DNA repair, and the death form of NSCLC cells were assessed after radiation therapy. The overexpression and silencing of receptor-interacting protein kinases 3 (RIP3, a key protein involved activation of necroptosis)-stable NSCLC cell lines were successfully constructed. The form of cell death, the number and area of colonies, and the regulatory proteins of necroptosis were characterized after radiation therapy in vitro. Finally, NSCLC xenografts and patient specimens were used to examine involvement of necroptosis after ablative HFRT in vivo. RESULTS: Radiation therapy induced expected DNA damage and repair of NSCLC cell lines, but ablative HFRT at ≥10 Gy per fraction preferentially stimulated necroptosis in NSCLC cells and xenografts with high RIP3 expression, as characterized by induction and activation of RIP3 and mixed-lineage kinase domain-like protein and release of immune-activating chemokine high-mobility group box 1. In contrast, RNA interference of RIP3 attenuated ablative HFRT-induced necroptosis and activation of its regulatory proteins. Among central early-stage NSCLC patients receiving stereotactic body radiation therapy, high expression of RIP3 was associated with improved local control and progression-free survival (all P < .05). CONCLUSIONS: Ablative HFRT at ≥10 Gy per fraction enhances killing of NSCLC with high RIP3 expression via preferential stimulation of necroptosis. RIP3 may serve as a useful biomarker to predict favorable response to stereotactic body radiation therapy.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Wang HH, Wu ZQ, Qian D, et al. Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis In Vitro and In Vivo. Int J Radiat Oncol Biol Phys. 2018. PMID: 29619976. doi:10.1016/j.ijrobp.2018.01.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。